{"altmetric_id":2595178,"counts":{"readers":{"mendeley":7,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["paulandrewburke"],"posts_count":1}},"selected_quotes":["And: Influence of AAV2-mediated gene xfer of hu IL-10 on neurodegeneration immune resp in murine Parkinson's model"],"citation":{"abstract":"The aim of this study was to examine the effect of AAV2-hIL-10 (vector containing cDNA for human interleukin 10) on dopaminergic system activity (measured as DA levels and TH mRNA expression in mouse striata), and other monoamine and amino acid neurotransmitters concentration as well as development of inflammatory processes (measured as TGF-\u03b2, IFN-\u03b3 and GFAP mRNA expression) in a murine MPTP neurotoxicant model of Parkinson's disease.","abstract_source":"pubmed","altmetric_jid":"4f6fa6343cf058f6100084db","doi":"10.1016\/j.pharep.2014.03.008","first_seen_on":"2014-08-18T12:47:40+00:00","issns":["17341140"],"journal":"Pharmacological Reports","last_mentioned_on":1408322224,"links":["http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1734114014001182"],"pmid":"24948069","publisher_subjects":[{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"}],"scopus_subjects":["Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"title":"The influence of AAV2-mediated gene transfer of human IL-10 on neurodegeneration and immune response in a murine model of Parkinson's disease ","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/influence-aav2mediated-gene-transfer-human-il10-neurodegeneration-immune-response-murine-model-parki-2"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":5036385,"mean":5.9659709716306,"rank":3553692,"this_scored_higher_than_pct":16,"this_scored_higher_than":836734,"rank_type":"exact","sample_size":5036385,"percentile":16},"similar_age_3m":{"total_number_of_other_articles":129371,"mean":8.3576561026515,"rank":87168,"this_scored_higher_than_pct":19,"this_scored_higher_than":25372,"rank_type":"exact","sample_size":129371,"percentile":19},"this_journal":{"total_number_of_other_articles":321,"mean":1.6157125,"rank":169,"this_scored_higher_than_pct":32,"this_scored_higher_than":104,"rank_type":"exact","sample_size":321,"percentile":32},"similar_age_this_journal_3m":{"total_number_of_other_articles":13,"mean":0.77083333333333,"rank":5,"this_scored_higher_than_pct":46,"this_scored_higher_than":6,"rank_type":"exact","sample_size":13,"percentile":46}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Student  > Doctoral Student":1,"Student  > Ph. D. Student":2,"Student  > Master":2,"Student  > Bachelor":2},"by_discipline":{"Neuroscience":2,"Psychology":1,"Agricultural and Biological Sciences":3,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"US":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/paulandrewburke\/status\/501165849555005440","license":"datasift","citation_ids":[2595178],"posted_on":"2014-08-18T00:37:04+00:00","author":{"name":"Paul Burke","url":"http:\/\/burkebioventures.com","image":"https:\/\/pbs.twimg.com\/profile_images\/560632088743792640\/WQY2Un8V_normal.jpeg","description":"Scientific & strategic direction for biopharma, focused on translating research-stage technology breakthroughs into products. New modalities\/nanotech\/delivery.","id_on_source":"paulandrewburke","tweeter_id":"432992338","geo":{"lt":42.3751,"ln":-71.10561,"country":"US"},"followers":1391},"tweet_id":"501165849555005440"}]}}